Redx Pharma Plc (REDX.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2018 | 09-2017 | 09-2016 | 09-2015 | 09-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,471 | 23,806 | 5,758 | 9,436 | 2,892 |
| Other current assets | 2,188 | 2,270 | 1,389 | 2,203 | 3,181 |
| TOTAL | $9,705 | $27,037 | $7,948 | $12,344 | $6,620 |
| Non-Current Assets | |||||
| PPE Net | 191 | 222 | 533 | 353 | 130 |
| Intangibles | 423 | 430 | 309 | 309 | 309 |
| Other Non-Current Assets | 0 | 0 | 605 | 750 | 0 |
| TOTAL | $614 | $652 | $1,447 | $1,412 | $439 |
| Total Assets | $10,319 | $27,689 | $9,395 | $13,756 | $7,059 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 0 | 2,000 | 0 | 2,000 |
| Accounts payable and accrued liabilities | 1,685 | 3,991 | 1,632 | 1,601 | 1,151 |
| TOTAL | $3,950 | $13,362 | $7,675 | $4,056 | $5,239 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 0 | 2,000 | 0 |
| Other Non-Current Liabilities | 605 | 0 | 0 | 0 | 0 |
| TOTAL | $605 | $0 | $0 | $2,000 | $0 |
| Total Liabilities | $4,555 | $13,362 | $7,675 | $6,056 | $5,239 |
| Shareholders' Equity | |||||
| Common Shares | 1,265 | 1,265 | 936 | 650 | 7 |
| Retained earnings | -29,927 | -21,082 | -22,610 | -7,089 | -10,652 |
| Other shareholders' equity | 1,162 | 880 | 867 | 622 | 152 |
| TOTAL | $5,764 | $14,327 | $1,720 | $7,700 | $1,820 |
| Total Liabilities And Equity | $10,319 | $27,689 | $9,395 | $13,756 | $7,059 |